Ellen Donnelly
Amministratore Delegato presso ABLIVA AB
Provenienza dei contatti di primo grado di Ellen Donnelly
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
13
| Public Company | Pharmaceuticals: Major | 13 |
| Public Company | Biotechnology | 11 | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
| Public Company | Biotechnology | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ellen Donnelly tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Undergraduate Degree | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Royal Institute of Technology | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Lund | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
Liberum Capital Ltd.
 Liberum Capital Ltd. Investment Banks/BrokersFinance Panmure Liberum Capital Ltd. (Panmure Liberum) is a brokerage firm headquartered in London, UK. The firm was founded by Shane Le Prevost in 2007 as Liberum Capital Ltd. In 2024, Panmure Liberum Ltd. (now known as LIB 123 Ltd.) acquired the firm from TN Holdings (BVI) Ltd. Headquartered in London, Liberum provides trading and execution services for institutional clients. They bring liquidity into the niches that matter and are market-makers in various large, mid and small-cap stocks. | Investment Banks/Brokers | Analyst-Equity | |
| PROMIMIC AB | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| KCIF Fund Management AB | Director/Board Member Director/Board Member | ||
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member | |
| LIDDS AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Investor Relations Contact | |
Maas Biolab LLC
 Maas Biolab LLC Pharmaceuticals: MajorHealth Technology Maas Biolab LLC manufactures vaccines for chronic neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's, and Alzheimer's. The American company was founded by Marcus Keep and Eskil Elmér, with Marcus Keep serving as CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| The Woodmark Group | Director/Board Member | ||
OBN (UK) Ltd.
 OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer General Counsel | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| OSSDSIGN AB | Medical Specialties | Director/Board Member Director of Finance/CFO | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Terrarock Ltd.
 Terrarock Ltd. Engineering & ConstructionIndustrial Services Part of Terra Mauricia Ltd., Terrarock Ltd. is a Mauritian company that provides geotechnical solutions and wholesales drilling equipment. The company is based in Fond du Sac, Mauritius. | Engineering & Construction | Director/Board Member Director/Board Member | |
| BIO-WORKS TECHNOLOGIES AB | Biotechnology | Chairman Chairman | |
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
SAGA Diagnostics AB
 SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Medical/Nursing Services | Corporate Officer/Principal | |
Mimir Capital AB
 Mimir Capital AB Investment ManagersFinance Mimir Capital AB (Mimir Capital) is a private equity firm founded in 2013. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Chairman Chief Executive Officer | |
| Stayble AB | Director/Board Member Director/Board Member | ||
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Hadean Ventures AS
 Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Investment Managers | Private Equity Investor | |
Lindemann Holding GmbH
 Lindemann Holding GmbH Financial ConglomeratesFinance Lindemann Holding GmbH is a company based in Moorrege, Germany. The CEOs of the German company are Hans Herbert Lindemann, Kerstin Benkendorf, Sven Lindemann. | Financial Conglomerates | Director/Board Member | |
| ZICCUM AB | Medical Specialties | Director/Board Member | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Ac Intressenter AB | Chairman Director/Board Member | ||
Sinfonia Biotherapeutics AB
 Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a clinical stage company based in Huddinge, Sweden. The Swedish company develops biologics for the treatment of neuropathic pain. | Biotechnology | Chairman Director/Board Member | |
| Alzecure Discovery AB | Chairman Chief Executive Officer | ||
HVentures Capital i AB
 HVentures Capital i AB Investment ManagersFinance HVentures Capital i AB provides private equity fund services. The private company is based in Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal | |
TargED Biopharmaceuticals BV
 TargED Biopharmaceuticals BV BiotechnologyHealth Technology TargED Biopharmaceuticals BV is a Dutch company that develops biological drugs. The company is based in Utrecht, Netherlands. The company was founded by Coen Maas, Kristof Vercruysse, Marc van Moorsel, Steven de Maat. Kristof Vercruysse has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Recion Oy | Director/Board Member Director/Board Member | ||
| Crosslanes Holding AB | Director/Board Member |
Statistiche
Distribuzione geografica
| Svezia | 38 |
| Regno Unito | 5 |
| Germania | 3 |
| Stati Uniti | 3 |
| Mauritius (isola) | 2 |
Settori
| Health Technology | 22 |
| Finance | 9 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Industrial Services | 2 |
Posizioni
| Director/Board Member | 220 |
| Corporate Officer/Principal | 62 |
| Chairman | 55 |
| Chief Executive Officer | 44 |
| Independent Dir/Board Member | 38 |
Contatti più connessi
- Borsa valori
- Insiders
- Ellen Donnelly
- Connessioni Società
